跳至主要内容
临床试验/CTRI/2022/12/048261
CTRI/2022/12/048261进行中(未招募)2 期

Effect of Kalingadi Churna (in constipation predominant) and Dadimastaka Churna (in diarrhea predominant) in Irritable Bowel Syndrome –A Randomized Controlled Clinical Trial ?

Dr RAJAT THAKUR0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Individuals between the age group of 20 to 60 years
  • patients of either sex
  • subjects fulfilling the diagnostic Rome 4 criteria

排除标准

  • Other subtypes of IBS like mixed and unclassified
  • Diagnosed with Inflammatory bowel disorders
  • Known case of CA colon, Intestinal tuberculosis
  • Patients with chronic alcoholism
  • Patients with any co-morbidities needs long term drug treatment, rheumatoid arthritis, tuberculosis, uncontrolled diabetes, HTN, etc.
  • Pregnant or lactating women .
  • Patient have an allergic reaction to Mebeverine in the past.
  • Patients on any medications for the management of IBS in the last 30 days

研究者

发起方
Dr RAJAT THAKUR

相似试验